Want to join the conversation?
$VRX said it received a unanimous FDA Advisory Committee vote for Brodalumab on July 19, 2016. The panel voted 18-0 in favor of this approval. Brodalumab showed statistical superiority versus Stelara, which has worldwide sales of over $2.7Bil in 2015. The drug also demonstrated impressive clearance rates and has a rapid onset of action.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.